Table 3.
Proportion of patients who reported adequate symptom relief
| Placebo group (n = 42) | Probiotics group (n = 39) | p value | |
|---|---|---|---|
| Total, n (%) | 26 (61.9) | 29 (74.4) | 0.230 |
| IBS-C | 5 (83.3) | 6 (66.7) | 0.604 |
| IBS-D | 12 (52.2) | 13 (81.3) | 0.063 |
| IBS-M | 6 (66.7) | 5 (62.5) | 1.0 |
| IBS-U | 3 (75.0) | 5 (83.3) | 1.0 |
IBS-C, IBS with constipation; IBS-D, IBS with diarrhea; IBS-M, mixed IBS; IBS-U, un-subtyped IBS.